RE: RE: RE: RE: RE: RE: RE: I hope...... JD, I most certainly agree with you on that; the timing of this is suspect given the fact they have announced, and reaffirmend that they plan to release further Interim Phase 2 data by the end of Q2(which is a matter of weeks).
I do see that being a major catalyst for us, given the fact that 007 is why we are all here in the first place, and hopefully if enough people voice their displeasure with management over the current state of affairs perhaps they can be urged to include efficacy. With the trial as advanced as it is at this point, there should be an abundance of information they COULD share(which could potentially catapult us if in line with phase 1 stuff), it is now a question of "will they".